Off-label prescribing for children with chronic diseases in Nigeria; findings and implications

References

• U.S. Food and Drug Administration. Understanding unapproved use of approved drugs “off label”; [ cited 2017 Apr 4]. Available from: https://www.fda.gov/ForPatients/Other/Offlabel/default.htm
   Google Scholar
• Gazarian M, Kelly M, McPhee JR, et al. Off-label use of medicines: consensus recommendations for evaluating appropriateness. Med J Aust. 2006;185:544–548.
   PubMed Web of Science ®Google Scholar
• Corny J, Lebel D, Bailey B, et al. Unlicensed and off-label drug use in children before and after pediatric governmental initiatives. J Pediatr Pharmacol Ther. 2015;20(4):316–328. .
   PubMedGoogle Scholar
• Magalhães J, Rodrigues AT, Roque F, et al. Use of off-label and unlicenced drugs in hospitalised paediatric patients: a systematic review. Eur J Clin Pharmacol. 2015;71:1–13 .
   PubMed Web of Science ®Google Scholar
• Aaargard L. Off-label and unlicensed prescribing of medicines in paediatric populations: occurrence and safety aspects. Basic Clin Pharmacol Toxicol. 2015;117:215–218.
   PubMed Web of Science ®Google Scholar
• Pharmaceutical and Medical Devices Agency (PMDA) of Japan. [ cited 2016 Jun 20]. Available from: http://www.pmda.go.jp/english/
   Google Scholar
• National Agency for Food and Drug Administration and Control. Drug resources; [ cited 2016 Jan 21]. Available from: http://www.nafdac.gov.ng/index.php/products/drugsmenu
   Google Scholar
• Neubert A, Wong IC, Bonifazi A, et al. Defining off-label and unlicensed use of medicines in children: results of a Delphi survey. Pharmacol Res. 2008;58:316–322.
   PubMed Web of Science ®Google Scholar
• Roth-Cline M, Nelson RM. Ethical considerations in conducting pediatric and neonatal research in clinical pharmacology. Curr Pharm Des. 2015;21:5619–5635.
   PubMed Web of Science ®Google Scholar
• Kimland E, Odlind V. Off-label drug use in pediatric patients. Clin Pharmacol Ther. 2012;91(5):796–801.
   PubMed Web of Science ®Google Scholar
• Saiyed MM, Lalwani T, Rana D. Off-label medicine use in pediatric inpatients: a prospective observational study at a tertiary care hospital in India. Int J Pediatr. 2014;2014:1–6.
   Google Scholar
• Okechuckwu RC, Aghomo OE. Prescription pattern of unlicensed and off-label medicines for children aged 0-5 years in a tertiary hospital and a primary health care centre in Nigeria. SAJBL. 2009;2:62–66.
   Google Scholar
• Osokogu OU, Dukanovic J, Ferrajolo C, et al. Pharmacoepidemiological safety studies in children: a systematic review. Pharmacoepidemiol Drug Saf. 2016;25:861–870.
   PubMed Web of Science ®Google Scholar
• Rosli R, Dali AF, Abd Aziz N, et al. Drug utilization on neonatal wards: a systematic review of observational studies. Front Pharmacol. 2017;8:27.
   PubMed Web of Science ®Google Scholar
• Rinke ML, Bundy DG, Shore AD, et al. Pediatric antidepressant medication errors in a national error reporting database. J Dev Behav Pediatr. 2010;31(2):129–136.
   PubMed Web of Science ®Google Scholar
• Hildtraud K. Off-label medicine use in children and adolescents: results of a population-based study in Germany. BMC Public Health. 2013;13:631.
   PubMed Web of Science ®Google Scholar
• Sharif SI. Trends of pediatric outpatients prescribing in Umm Al Quwain: United Arab Emirates. Pharmacol Pharm. 2015;6:9–16.
   Google Scholar
• Turner S, Nunn AJ, Fielding K, et al. Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: a prospective study. Acta Paediatr. 1999;88:965–968.
   PubMed Web of Science ®Google Scholar
• Horen B, Montastruc JL, Lapeyre-Mestre M. Adverse drug reactions and off-label drug use in paediatric outpatients. Br J Clin Pharmacol. 2002;54:665–670.
   PubMed Web of Science ®Google Scholar
• Jonville-Béra AP, Béra F, Autret-Leca E. Are incorrectly used drugs more frequently involved in adverse drug reactions? A prospective study. Eur J Clin Pharmacol. 2005;61:231–236.
   PubMed Web of Science ®Google Scholar
• Ufer M, Kimland E, Bergman U. Adverse drug reactions and off-label prescribing for paediatric outpatients: a one-year survey of spontaneous reports in Sweden. Pharmacoepidemiol Drug Saf. 2004;13:147–152.
   PubMed Web of Science ®Google Scholar
• Aagaard L, Hansen EH. Prescribing of medicines in the Danish paediatric population out with the licensed age group: characteristics of adverse drug reactions. Br J Clin Pharmacol. 2011;71:751–757 .
   PubMed Web of Science ®Google Scholar
• Czaja AS, Reiter PD, Schultz ML, et al. Patterns of off-label prescribing in the pediatric intensive care unit and prioritizing future research. J Pediatr Pharmacol Ther. 2015;20:186–196 .
   PubMedGoogle Scholar
• Langerová P, Vrtal J, Urbánek K. Incidence of unlicensed and off-label prescription in children. Italian J Pediatr. 2014;40:12.
   PubMed Web of Science ®Google Scholar
• Knopf H, Wolf IK, Sarganas G, et al. Off-label medicine use in children and adolescents: results of a population-based study in Germany. BMC Public Health. 2013;13:631.
   PubMed Web of Science ®Google Scholar
• European Medicines Agency. Report on the survey of all paediatric uses of medicinal products in Europe. Edition 2010 Dec 10, EMA/794083/2009. [cited 2012 Sep 18]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Report/2011/01/WC500101006.pdf
   Google Scholar
• Oshikoya KA, Senbanjo IO, Njokanma OF, et al. Use of complementary and alternative medicines for children with chronic health conditions in Lagos, Nigeria. BMC Complement Altern Med. 2008;8:66.
   PubMed Web of Science ®Google Scholar
• Federal Republic of Nigeria. Essential Medicines List, 5th Revision; 2010 [cited 2017 Apr 11]. Available from: http://www.health.gov.ng/doc/EML.pdf
   Google Scholar
• Boulet LP, Boulay MÈ. Asthma-related comorbidities. Expert Rev Respir Med. 20115;3:377–393.
   Web of Science ®Google Scholar
• Seidenberg M, Pulsipher DT, Hermann B. Association of epilepsy and comorbid conditions. Future Neurol. 2009;4(5):663–668.
   PubMedGoogle Scholar
• Mahdi N, Al-Ola K, Khalek NA, et al. Depression, anxiety, and stress comorbidities in sickle cell anemia patients with vaso-occlusive crisis. J Pediatr Hematol Oncol. 2010;32(5):345–349.
   PubMed Web of Science ®Google Scholar
• Oshikoya KA, Edun B, Oreagba IA. Acute pain management in children with sickle cell anaemia during emergency admission to a teaching hospital in Lagos, Nigeria. S Afr J Child Health. 2015;9(4):119–123.
   Google Scholar
• Franco V, Canevini MP, Capovilla G, et al. Off-label prescribing of antiepileptic drugs in pharmacoresistant epilepsy: a cross-sectional drug utilization study of tertiary care centers in Italy. CNS Drugs. 2014;28:939–949.
   PubMed Web of Science ®Google Scholar
• ‘t Jong GW, Eland IA, Sturkenboom MCJM, et al. Unlicensed and off-label prescription of respiratory drugs to children. Eur Resp J. 2004;23:310–313.
   PubMed Web of Science ®Google Scholar
• Morais-Almeida M, Cabral AJ. Off-label prescribing for allergic diseases in pre-school children. Allergol Immunopathol (Madr). 2014;42:342–347.
   PubMed Web of Science ®Google Scholar
• Lagos University Teaching Hospital. [ cited 2015 Mar 17]. Available from: http://luthnigeria.org/locations/view/luth-main-campus-idi-araba
   Google Scholar
• Harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH Harmonised Tripartite Guideline E11 for clinical investigation of medicinal products in the paediatric population. Current Step 4 version; 2000 Jul 20 [cited 2017 Apr 11]. Available from: http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E11/Step4/E11_Guideline.pdf
   Google Scholar
• US Food and Drug Administration. Prescription drugs and over-the-counter (OTC) drugs: questions and answers; [ cited 2015 Oct 10]. Available from: https://www.fda.gov/drugs/resourcesforyou/consumers/questionsanswers/ucm100101.htm
   Google Scholar
• Bachhav SS, Kshirsagar NA. Systematic review of drug utilization studies and the use of the drug classification system in the WHO-SEARO region. Indian J Med Res. 2015;142:120–129.
   PubMed Web of Science ®Google Scholar
• British National Formulary for Children (BNFC). London: BMJ Group and Royal Pharmaceutical Society of Great Britain; 2014–2015.
   Google Scholar
• AHFS. AHFS drug information. 1st ed. American Society of Health-System Pharmacists. Maryland:Mathews Book Company; 2015.
   Google Scholar
• Taketomo CK. Pediatric and neonatal dosage handbook with international trade names index. 21st ed. Hudson: Lexi-Comp Incorporated; 2014.
   Google Scholar
• Schmiedl S, Fischer R, Ibáñez L, et al. Utilisation and off-label prescriptions of respiratory drugs in children. PLoS One. 2014;9:e105110.
   PubMed Web of Science ®Google Scholar
• Aripin KN, Choonara I, Sammons HM. A systematic review of paediatric randomised controlled drug trials published in 2007. Arch Dis Child. 2010; 95:469–473.
   PubMed Web of Science ®Google Scholar
• Oshikoya KA, Orji MU, Oreagba IA. Medication history documentation in referral letters of children presenting at the emergency unit of a teaching hospital in Lagos, Nigeria. Ann Ibd Pg Med. 2015;13:16–23.
   Google Scholar